A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: NKTR-214
- DRUG: Nivolumab
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
- [object Object]
- [object Object]
- [object Object]